These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 12438288

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.
    Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, Staberock M, de Feyter P, Müller R, Regar E, Degertekin M, Ligthart JM, Disco C, Backx B, Russell ME.
    Circulation; 2003 Feb 04; 107(4):559-64. PubMed ID: 12566366
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
    Kastrati A, Dibra A, Mehilli J, Mayer S, Pinieck S, Pache J, Dirschinger J, Schömig A.
    Circulation; 2006 May 16; 113(19):2293-300. PubMed ID: 16682614
    [Abstract] [Full Text] [Related]

  • 9. Pathological features of in-stent restenosis after sirolimus-eluting stent versus bare metal stent placement.
    Abe S, Yoneda S, Kanaya T, Oda K, Nishino S, Kageyama M, Taguchi I, Masawa N, Inoue T.
    Cardiovasc Pathol; 2012 May 16; 21(2):e19-22. PubMed ID: 21489821
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M, El-Ramly M, Hassan A, Boshra H, AbdelWahab A.
    Cardiovasc Revasc Med; 2017 Dec 16; 18(8):596-600. PubMed ID: 28625402
    [Abstract] [Full Text] [Related]

  • 14. Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results.
    Strauss BH, Umans VA, van Suylen RJ, de Feyter PJ, Marco J, Robertson GC, Renkin J, Heyndrickx G, Vuzevski VD, Bosman FT.
    J Am Coll Cardiol; 1992 Dec 16; 20(7):1465-73. PubMed ID: 1360479
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment.
    Chung IM, Gold HK, Schwartz SM, Ikari Y, Reidy MA, Wight TN.
    J Am Coll Cardiol; 2002 Dec 18; 40(12):2072-81. PubMed ID: 12505216
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
    Kufner S, Massberg S, Dommasch M, Byrne RA, Tiroch K, Ranftl S, Fusaro M, Schömig A, Kastrati A, Mehilli J, Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents Trial Investigators.
    Catheter Cardiovasc Interv; 2011 Aug 01; 78(2):161-6. PubMed ID: 21400652
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.